Journal article icon

Journal article

Dapsone as first line therapy for bullous pemphigoid.

Abstract:

In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient). Overall, eight patients were controlled on one of these agents as the sole treatment (44%). Six patients had a partial, but inadequate response, while four did not respond. The responses to the sulpha drugs were generally rapid, i.e. within 2 weeks, and the maximum doses used in any patient were 100 mg/da...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Journal:
The British journal of dermatology
Volume:
120
Issue:
1
Pages:
83-92
Publication date:
1989-01-05
DOI:
EISSN:
1365-2133
ISSN:
0007-0963
URN:
uuid:687f91e7-d1ee-42b7-bb03-532d86d0e80f
Source identifiers:
12098
Local pid:
pubs:12098

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP